News & Perspective

Sep 10, 2009

Sep 10, 2009

Early results suggest 1 dose of H1N1 vaccine may be protective

(CIDRAP News) – Preliminary clinical trial results suggest that pandemic H1N1 vaccines made by Novartis and CSL Ltd. will provide protection in adults with just one dose, raising hope for a less difficult immunization program than has been anticipated.

Aug 28, 2009

Aug 28, 2009

WHO cites severe H1N1 cases as southern outbreaks wane

(CIDRAP News) – Novel H1N1 influenza outbreaks are starting to wane in the southern hemisphere, and while most cases are still mild, clinicians are reporting some severe cases of viral pneumonia in young, previously healthy people, the World Health Organization (WHO) said today.

Aug 27, 2009

Aug 27, 2009

FAO concerned about H1N1 poultry outbreak in Chile

Aug 27, 2008 (CIDRAP News) – The United Nations Food and Agriculture Organization (FAO) said today that the recent novel H1N1 influenza outbreak in turkeys in Chile points up the possibility of poultry outbreaks elsewhere, increasing the risk of H1N1 mixing with the more deadly H5N1 avian flu virus.

Aug 18, 2009

Aug 18, 2009

FDA clears CSL's vaccine-finishing facility in US

(CIDRAP News) – The US Food and Drug Administration (FDA) today approved a vaccine filling and packaging facility in Illinois owned by CSL Biotherapies, one of the five companies under contract to make novel H1N1 vaccines for the United States, the company announced.

Aug 14, 2009

Aug 14, 2009

Officials lower expectations for size of first novel flu vaccine deliveries

(CIDRAP News) – Federal officials today during a pandemic H1N1 planning update dialed back the number of novel flu vaccine doses they expect in October from 120 million to 45 million, listing several reasons for the smaller projection.

Aug 06, 2009

Aug 06, 2009

WHO says H1N1 vaccine process won't sacrifice safety

(CIDRAP News) – The World Health Organization (WHO) said today that the fast-tracking of vaccines for pandemic H1N1 influenza won't compromise safety, while acknowledging that clinical data will be limited when the first doses are administered.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»